# Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression

> **NCT00188643** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 40 (—)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Venlafaxine and Lamotrigine

## Key facts

- **NCT ID:** NCT00188643
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00188643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00188643, "Venlafaxine Versus Lamotrigine in the Treatment of Bipolar I/II Depression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00188643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*